Based on a survey of cardiologist and pulmonologists treating patients for pulmonary arterial hypertension (PAH), analysts at ...

Research analysts at Leerink Partnrs reduced their Q4 2024 earnings per share (EPS) estimates for shares of BridgeBio Pharma ...

In a report released yesterday, Puneet Souda from Leerink Partners maintained a Hold rating on Myriad Genetics (MYGN – Research Report), with a ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Hologic (HOLX – Research Report) yesterday and set a price target of $80.00.

Analysts at Leerink Partnrs upped their FY2024 EPS estimates for Mirum Pharmaceuticals in a research report issued to clients ...

X Genomics Inc (TXG) stock saw a decline, ending the day at $14.9 which represents a decrease of $-1.41 or -8.65% from the prior close of $16.31. The stock opened at $16.1 and touched a low of $14.19 ...

Less than a day into his second term, President Donald Trump ordered a freeze on communications at major public health ...

Elanco Animal Health Inc (ELAN) stock saw a decline, ending the day at $12.06 which represents a decrease of $-0.04 or -0.33% from the prior close of $12.1. The stock opened at $12.18 and touched a ...

CEO Joaquin Duato said the company is positioned for sustained growth in coming years even as competition batters Stelara, ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

During his presentation at the J.P. Morgan Healthcare Conference last week, Incyte CEO Hervé Hoppenot took investors on a ...

Jefferies, Leerink Partners, Stifel and Cantor are acting as joint book-running managers for the proposed offering. The securities described above are being offered by Disc pursuant to an ...